About
Basic Data Updated:
10 days agoIt is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532488 and on the National Stock Exchange(NSE) under DIVISLAB.
The Corporate was formerly known as Divi's Research Centre Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 60.00 cr and a paid-up capital of Rs 53.09 cr.
The Corporate currently has active open charges totaling ₹520.00 cr. It has already closed loans amounting to ₹671.72 cr, as per the Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Divi's Laboratories Limited India are Kishore Lingamneni as Cfo, Satchandra Divi as Ceo, and Satish Meka as Company Secretary. Nimmagadda Ramana, Murali Divi, Satchandra Divi, and Seven other members serve as directors at the Company.
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
Products or Services related to Divi's Laboratories Limited
Product Development Research
Lutein Powder
Herbal Capsules
Lycopene
Financials of Divi'S Laboratories Limited
Divi'S Laboratories Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.31% decrease. The company also saw a substantial fall in profitability, with a 38.68% decrease in profit. The company's net worth moved up by a moderate rise of 8.67%.
Corporate Structure
Unlock access to Divi'S Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Divi'S Laboratories Limited
Unlock and access historical data on people associated with Divi'S Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (4)
MD
Murali Divi
Managing DirectorAppointment Date: 12-Oct-1990
Status: Current
KL
Kishore Lingamneni CFOAppointment Date: 24-May-2014
Status: Current
SD
Satchandra Divi CEOAppointment Date: 04-Jan-2020
Status: Current
SM
Satish Meka Company SecretaryAppointment Date: 10-Aug-2019
Status: Current
Board Members(9)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Feb 2019 | ₹60.50 Cr | Open |
Industrial Development Bank Of India Creation Date: 06 Feb 2000 | ₹5.00 Cr | Open |
State Bank Of India Creation Date: 14 Dec 1995 | ₹454.50 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Divi'S Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Divi'S Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Divi'S Properties Private Limited
Active
19 years 6 months Murali Divi, Satchandra Divi and 1 more are mutual person
Recent activity within the organization
Director Appointment
Rajendra Kumar Premchand was appointed as a Director was appointed as a Director on 08 Jun 2024 & has been associated with this company since 3 months 15 days .
08 Jun 2024Director Appointment
Devendra Rao Sureddy was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 06 Mar 2024 & has been associated with this company since 6 months 18 days .
06 Mar 2024Annual General Meeting
Divi'S Laboratories Limited last Annual general meeting of members was held on 28 Aug 2023 as per latest MCA records.
28 Aug 2023Balance Sheet
Divi'S Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Charges
A charge with State Bank Of India of Rs. 454.50 cr registered on 14 Dec 1995 with Charge ID 90137808 was modified on 07 Apr 2022.
07 Apr 2022
Recent News, Updates & Announcement
- Pharma Problems Struggling with Pricing and Demand Amidst Pandemic But Stabilization Expected Soon for Generic Drugs.
When you thought your business was doing well but then the pandemic hit and now youre struggling with pricing and demand for your generic drugs But dont worry prices are expected to stabilize soon Meanwhile your rival is also facing similar issues PharmaProblems StruggleIsReal.
mint 14 Aug 2023
- Divis Labs surges 21 as USFDA to lift import alert for Visakhapatnam unit.
Business Standard 16 Jun 2023
- Divis Labs Q4 Results Cons PAT slumps 64 YoY to Rs 321 crore Rs 30share dividend declared.
Operating profit calculated as earnings before interest taxes depreciation and amortization EBITDA plunged 56 YoY to Rs 488 crore in Q4 and operating margin shrunk a whopping 1886 basis points to 2499.
Economic Times 20 May 2023
- Divis Labs Preview Unfavourable base elevated input costs to turn Q4 a sour pill.
Moneycontrol 19 May 2023
Frequently asked questions
What is the Incorporation or founding date of Divi'S Laboratories Limited?
